STOCK TITAN

Emeren Group Financials

SOL
FY2024 annual
Revenue $92.1M -12.9% YoY
Net Income -$12.5M -291.6% YoY
EPS (Diluted) -$0.24 -300.0% YoY
Free Cash Flow -$20.0M +41.5% YoY
Source SEC Filings (10-K/10-Q) Data as of Sep 30, 2025 Currency USD FYE December

Emeren Group (SOL) reported $92.1M in revenue for fiscal year 2024, down 12.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SOL FY2024

Cost discipline and working-capital release pushed the core business near breakeven, but reinvestment kept cash flow negative.

From FY2023 to FY2024, operating cash flow moved from -$23.5M to -$4.3M even as net loss moved the other way. With operating margin nearly breakeven at -0.5% but free cash flow still at -$20.0M, the data suggests the headline loss was shaped more by below-operating items and reinvestment than by the core cost structure.

FY2024 looks less like a demand-led recovery than a cost-structure reset: revenue slipped, yet gross margin improved to 26.2% and SG&A fell by about $2.8M, leaving the operating line only slightly negative. That pattern fits margin repair through cost discipline or mix, not simple fixed-cost absorption.

The balance sheet still shows cash above long-term debt, with $50.0M on hand against $23.5M of long-term borrowings and a current ratio of 3.9x. That gives room to keep investing, but capital spending absorbed more cash than operations did in FY2024, so cash usage now reflects portfolio build-out more than a short-term liquidity squeeze.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 64 / 100
Financial Health Score 64/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2024. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Emeren Group's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
96
Dilution
78
R&D Intensity
0

Not available for Emeren Group, and counted as zero in the overall score.

Revenue Progress
72
Burn Trend
83
Balance Sheet
56
Altman Z-Score Distress
-0.29

Emeren Group scores -0.29, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($99.6M) relative to total liabilities ($109.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Weak
3/9

Emeren Group passes 3 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Emeren Group reported a net loss of $12.5M while operations used $4.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Emeren Group reported an operating loss of $504K against $800K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$92.1M
YoY-12.9%
5Y CAGR-5.0%
10Y CAGR-24.7%

Emeren Group generated $92.1M in revenue in fiscal year 2024. This represents a decrease of 12.9% from the prior year.

EBITDA
$6.4M
YoY+871.5%
5Y CAGR-1.3%
10Y CAGR-23.9%

Emeren Group's EBITDA was $6.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 871.5% from the prior year.

Net Income
-$12.5M
YoY-291.6%

Emeren Group reported -$12.5M in net income in fiscal year 2024. This represents a decrease of 291.6% from the prior year.

EPS (Diluted)
-$0.24
YoY-300.0%

Emeren Group earned -$0.24 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 300.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$20.0M
YoY+41.5%

Emeren Group recorded an outflow of $20.0M in free cash flow in fiscal year 2024, representing a cash shortfall after capex. This represents an increase of 41.5% from the prior year.

Cash & Debt
$50.0M
YoY-28.7%
5Y CAGR+15.5%
10Y CAGR-6.7%

Emeren Group held $50.0M in cash against $23.5M in long-term debt as of fiscal year 2024.

Shares Outstanding
513M
YoY-6.0%
5Y CAGR+1.3%

Emeren Group had 513M shares outstanding in fiscal year 2024. This represents a decrease of 6.0% from the prior year.

Dividends Per Share

Not reported for fiscal year 2024.

Margins & Returns

Gross Margin
26.2%
YoY+2.5pp
5Y CAGR-2.5pp
10Y CAGR+12.8pp

Emeren Group's gross margin was 26.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 2.5 percentage points from the prior year.

Operating Margin
-0.5%
YoY+7.6pp
5Y CAGR+0.3pp
10Y CAGR-1.1pp

Emeren Group's operating margin was -0.5% in fiscal year 2024, reflecting core business profitability. This is up 7.6 percentage points from the prior year.

Net Margin
-13.6%
YoY-10.5pp
5Y CAGR-6.1pp
10Y CAGR-11.4pp

Emeren Group's net profit margin was -13.6% in fiscal year 2024, showing the share of revenue converted to profit. This is down 10.5 percentage points from the prior year.

Return on Equity
-4.2%
YoY-3.2pp
5Y CAGR+5.2pp
10Y CAGR+20.7pp

Emeren Group's ROE was -4.2% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 3.2 percentage points from the prior year.

Capital Allocation

Share Buybacks
$7.2M
YoY-67.1%

Emeren Group spent $7.2M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 67.1% from the prior year.

Capital Expenditures
$15.7M
YoY+46.5%
5Y CAGR+2.8%
10Y CAGR-11.2%

Emeren Group invested $15.7M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 46.5% from the prior year.

R&D Spending

Not reported for fiscal year 2024.

SOL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SOL annual income statement
MetricTTMFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11FY10
Revenue$71.2M$92.1M-12.9%$105.6M+72.4%$61.3M-23.1%$79.7M+8.4%$73.5M-38.3%$119.1M+22.9%$96.9M-5.9%$103.0M+27.9%$80.5M-30.8%$116.3M-92.6%$1.6B+2.8%$1.5B+56.8%$969.1M-1.6%$985.3M-18.3%$1.2B
Cost of Revenue$47.0M$67.9M-15.7%$80.6M+75.5%$46.0M-4.7%$48.2M-15.1%$56.8M-33.1%$84.9M+23.3%$68.8M-22.5%$88.8M+21.3%$73.3M-21.5%$93.3M-93.1%$1.4B-3.9%$1.4B+39.6%$1.0B+13.3%$889.2M+3.7%$857.6M
Gross Profit$24.2M$24.1M-3.6%$25.0M+63.1%$15.3M-51.2%$31.4M+88.3%$16.7M-51.2%$34.2M+21.9%$28.1M+98.6%$14.1M+95.4%$7.2M-68.6%$23.0M-89.0%$209.3M+85.0%$113.1M+396.6%-$38.1M-139.7%$96.1M-72.4%$348.0M
R&D ExpensesN/AN/AN/AN/AN/AN/AN/AN/AN/A$27.3M-37.9%$43.9M-16.5%$52.6M+13.2%$46.5M+5.3%$44.1M-6.3%$47.1M+29.8%$36.3M
SG&A Expenses$24.7M$23.1M-10.9%$26.0M+50.9%$17.2M+1.2%$17.0M+17.1%$14.5M-7.9%$15.8M+54.5%$10.2M+65.1%$6.2M-9.5%$6.8M-7.6%$7.4M-89.0%$67.3M+21.0%$55.6M+9.3%$50.9M+32.0%$38.5M-11.0%$43.3M
Operating Income-$35.5M-$504K+94.2%-$8.7M-228.9%-$2.6M-120.8%$12.7M+86.6%$6.8M+803.1%-$964K-106.2%$15.5M+136.9%$6.6M+179.1%$2.3M-85.6%$16.3M+98.6%$8.2M+103.7%-$221.4M-23.7%-$179.0M-1651.1%$11.5M-95.3%$245.9M
Interest Expense$1.9M$800K-63.7%$2.2M-30.4%$3.2M-38.6%$5.2M-17.0%$6.2M-32.2%$9.2M+5.2%$8.7M+121.1%$3.9M+113.7%$1.8M-7.9%$2.0M-95.9%$49.0M-5.9%$52.1M+2.9%$50.6M+36.1%$37.2M+60.0%$23.2M
Income Tax$2.3M$2.0M-20.1%$2.5M+31.9%$1.9M+147.5%$774K+375.0%$163K-85.2%$1.1M+685.3%-$189K-158.6%$322K+143.8%$132K+669.6%-$23K+93.4%-$350K+87.1%-$2.7M-112.8%$21.4M+540.1%-$4.9M-108.1%$60.0M
Net Income-$9.1M-$12.5M-291.6%-$3.2M+31.8%-$4.7M-168.1%$6.9M+146.9%$2.8M+131.5%-$8.8M-601.9%$1.8M-94.9%$34.5M+199.3%-$34.7M-583.7%-$5.1M+84.9%-$33.6M+87.0%-$258.9M-6.7%-$242.6M-73342.9%$331K-99.8%$169.0M
EPS (Diluted)-$0.24-300.0%-$0.06+14.3%-$0.07-170.0%$0.10+66.7%$0.06+127.3%-$0.22$0.00-100.0%$0.13-$0.17-750.0%-$0.02+88.2%-$0.17+88.0%-$1.42-1.4%-$1.40$0.00-100.0%$0.97

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SOL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SOL annual balance sheet
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11FY10
Total Assets$447.6M-6.4%$478.4M-3.1%$493.9M-6.7%$529.3M+57.1%$336.9M+5.3%$319.9M-15.3%$377.7M+12.5%$335.7M-69.2%$1.1B-19.2%$1.3B-19.3%$1.7B-22.0%$2.1B+4.0%$2.1B+5.6%$1.9B+22.3%$1.6B
Current Assets$191.4M-15.5%$226.4M+2.6%$220.7M-32.9%$329.2M+140.7%$136.7M+32.7%$103.1M-23.8%$135.3M-20.5%$170.1M-66.5%$507.5M-20.4%$637.8M-25.8%$859.5M-28.8%$1.2B+38.1%$873.8M+4.9%$832.9M+19.3%$698.0M
Cash & Equivalents$50.0M-28.7%$70.2M-34.5%$107.1M-57.8%$254.1M+525.9%$40.6M+67.1%$24.3M+259.9%$6.8M-49.7%$13.4M+238.7%$4.0M-89.6%$38.0M-61.9%$99.8M+15.1%$86.8M-7.0%$93.3M-75.4%$379.0M+30.4%$290.7M
InventoryN/AN/AN/AN/AN/AN/AN/AN/A$144.0M-25.5%$193.2M-45.9%$357.4M-0.6%$359.6M+41.1%$254.9M+65.3%$154.2M-9.6%$170.6M
Accounts Receivable$21.1M-22.1%$27.1M+25.0%$21.7M-36.7%$34.3M+69.9%$20.2M+45.9%$13.8M-59.9%$34.5M+47.9%$23.3M+27023.5%$86K-99.9%$117.6M+5.0%$112.0M-52.7%$236.6M+9.1%$216.8M+67.3%$129.6M+59.0%$81.5M
GoodwillN/A$0-100.0%$1.0M0.0%$1.0M0.0%$1.0M$0N/AN/AN/AN/AN/AN/AN/A$5.6M+6.1%$5.3M
Total Liabilities$109.5M-4.8%$115.0M+9.3%$105.2M+30.1%$80.9M-47.4%$153.7M-15.7%$182.4M-27.9%$253.0M+3.2%$245.2M-76.0%$1.0B-17.2%$1.2B-19.5%$1.5B-22.2%$2.0B+16.3%$1.7B+25.7%$1.3B+33.8%$1.0B
Current Liabilities$49.5M-13.1%$57.0M+31.6%$43.3M+23.4%$35.1M-60.3%$88.3M-19.3%$109.4M-18.2%$133.7M-7.9%$145.2M-83.9%$904.4M-18.1%$1.1B-17.4%$1.3B-22.0%$1.7B+18.8%$1.4B+45.8%$989.4M+27.1%$778.2M
Long-Term Debt$23.5M+3.7%$22.7MN/AN/AN/AN/AN/AN/AN/AN/A$43.5MN/AN/AN/AN/A
Total Equity$300.5M-7.6%$325.3M-6.3%$347.3M-14.0%$404.0M+190.4%$139.1M+46.9%$94.7M+4.5%$90.7M+0.2%$90.5M+36.8%$66.1M-40.9%$111.9M-17.2%$135.2M-20.0%$169.0M-53.6%$364.4M-39.4%$601.0M+2.5%$586.5M
Retained Earnings-$453.0M-2.8%-$440.6M-0.7%-$437.4M-1.1%-$432.7M+1.6%-$439.6M+0.6%-$442.3M-2.0%-$433.5M+0.5%-$435.5M+7.3%-$470.0M-8.0%-$435.3M-1.2%-$430.2M-8.5%-$396.6M-188.1%-$137.7M-231.3%$104.9M-3.3%$108.4M

SOL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SOL annual cash flow statement
MetricTTMFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11FY10
Operating Cash Flow$44.8M-$4.3M+81.7%-$23.5M+38.2%-$38.0M-523.1%-$6.1M+39.2%-$10.0M-117.9%$55.9M+209.4%-$51.1M-377.2%$18.4M-33.1%$27.5M+1146.1%$2.2M+101.8%-$121.7M-202.6%$118.6M+225.2%-$94.7M-329.5%-$22.1M-105.5%$403.2M
Capital Expenditures$11.1M$15.7M+46.5%$10.7M-71.4%$37.6M+223.8%$11.6M+40.9%$8.2M-39.8%$13.7M-66.1%$40.4M-49.7%$80.3M$0$0-100.0%$51.8M-42.5%$90.1M-20.6%$113.5M-14.5%$132.8M-3.5%$137.7M
Free Cash Flow$33.7M-$20.0M+41.5%-$34.2M+54.7%-$75.6M-326.9%-$17.7M+3.1%-$18.3M-143.3%$42.2M+146.1%-$91.5M-47.8%-$61.9M-324.8%$27.5M+1146.1%$2.2M+101.3%-$173.5M-710.5%$28.4M+113.6%-$208.3M-34.5%-$154.9M-158.3%$265.5M
Investing Cash Flow-$9.9M-$15.5M-201.1%$15.3M+134.5%-$44.4M-331.1%$19.2M+667.6%-$3.4M-112.1%-$1.6M+96.0%-$40.4M+74.2%-$156.4M-470.9%$42.2M+205.3%-$40.0MN/AN/AN/AN/AN/A
Financing Cash Flow$22.0M-$5.8M+76.8%-$25.3M+58.1%-$60.3M-129.5%$204.6M+578.1%$30.2M+176.8%-$39.3M-145.8%$85.8M-16.2%$102.4M+264.2%-$62.4M-459.0%-$11.2MN/AN/AN/AN/AN/A
Share BuybacksN/A$7.2M-67.1%$21.9M-49.8%$43.7M+136.8%$18.4M$0$0$0$0-100.0%$1.5M+83.9%$812KN/AN/AN/A$1.9MN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SOL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SOL annual financial ratios
MetricFY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11FY10
Gross Margin26.2%+2.5pp23.7%-1.3pp25.0%-14.4pp39.5%+16.8pp22.7%-6.0pp28.7%-0.2pp29.0%+15.3pp13.7%+4.7pp9.0%-10.8pp19.8%+6.4pp13.4%+6.0pp7.4%+11.4pp-3.9%-13.7pp9.8%-19.1pp28.9%
Operating Margin-0.5%+7.6pp-8.2%-3.9pp-4.3%-20.2pp15.9%+6.7pp9.2%+10.0pp-0.8%-16.8pp16.0%+9.7pp6.4%+3.5pp2.9%-11.1pp14.0%+13.5pp0.5%+15.1pp-14.6%+3.9pp-18.5%-19.6pp1.2%-19.2pp20.4%
Net Margin-13.6%-10.5pp-3.0%+4.6pp-7.6%-16.2pp8.6%+4.8pp3.8%+11.2pp-7.4%-9.2pp1.8%-31.6pp33.5%+76.6pp-43.1%-38.7pp-4.4%-2.2pp-2.1%+14.9pp-17.0%+8.0pp-25.0%-25.1pp0.0%-14.0pp14.0%
Return on Equity-4.2%-3.2pp-1.0%+0.4pp-1.4%-3.0pp1.7%-0.3pp2.0%+11.3pp-9.3%-11.3pp1.9%-36.1pp38.1%+90.5pp-52.5%-47.9pp-4.5%+20.4pp-24.9%+128.3pp-153.2%-86.6pp-66.6%-66.6pp0.1%-28.8pp28.8%
Return on Assets-2.8%-2.1pp-0.7%+0.3pp-0.9%-2.3pp1.3%+0.5pp0.8%+3.6pp-2.8%-3.2pp0.5%-9.8pp10.3%+13.5pp-3.2%-2.8pp-0.4%+1.6pp-2.0%+10.1pp-12.1%-0.3pp-11.8%-11.8pp0.0%-10.6pp10.6%
Current Ratio3.87-0.1x3.97-1.1x5.10-4.3x9.38+7.8x1.55+0.6x0.94-0.1x1.01-0.2x1.17+0.6x0.560.0x0.58-0.1x0.64-0.1x0.70+0.1x0.61-0.2x0.84-0.1x0.90
Debt-to-Equity0.080.0x0.07-0.2x0.30+0.1x0.20-0.9x1.10-0.8x1.93-0.9x2.79+0.1x2.71-12.7x15.45+4.4x11.03+10.7x0.32-11.3x11.66+7.0x4.65+2.4x2.24+0.5x1.72
FCF Margin-21.8%+10.6pp-32.4%-123.4%-22.2%+2.6pp-24.9%-60.3pp35.4%+129.8pp-94.4%-34.3pp-60.1%-94.3pp34.2%+32.3pp1.9%+13.0pp-11.1%-13.0pp1.9%+23.4pp-21.5%-5.8pp-15.7%-37.7pp22.0%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Similar Companies

Frequently Asked Questions

What is Emeren Group's annual revenue?

Emeren Group (SOL) reported $92.1M in total revenue for fiscal year 2024. This represents a -12.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Emeren Group's revenue growing?

Emeren Group (SOL) revenue declined by 12.9% year-over-year, from $105.6M to $92.1M in fiscal year 2024.

Is Emeren Group profitable?

No, Emeren Group (SOL) reported a net income of -$12.5M in fiscal year 2024, with a net profit margin of -13.6%.

Emeren Group (SOL) reported diluted earnings per share of -$0.24 for fiscal year 2024. This represents a -300.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Emeren Group (SOL) had EBITDA of $6.4M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2024, Emeren Group (SOL) had $50.0M in cash and equivalents against $23.5M in long-term debt.

Emeren Group (SOL) had a gross margin of 26.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

Emeren Group (SOL) had an operating margin of -0.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

Emeren Group (SOL) had a net profit margin of -13.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Emeren Group (SOL) has a return on equity of -4.2% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Emeren Group (SOL) recorded an outflow of $20.0M in free cash flow during fiscal year 2024. This represents a 41.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Emeren Group (SOL) recorded an outflow of $4.3M in operating cash flow during fiscal year 2024, representing cash used by core business activities.

Emeren Group (SOL) had $447.6M in total assets as of fiscal year 2024, including both current and long-term assets.

Emeren Group (SOL) invested $15.7M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

Yes, Emeren Group (SOL) spent $7.2M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.

Emeren Group (SOL) had 513M shares outstanding as of fiscal year 2024.

Emeren Group (SOL) had a current ratio of 3.87 as of fiscal year 2024, which is generally considered healthy.

Emeren Group (SOL) had a debt-to-equity ratio of 0.08 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Emeren Group (SOL) had a return on assets of -2.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2024 data, Emeren Group (SOL) had $50.0M in cash against an annual operating cash burn of $4.3M. This gives an estimated cash runway of approximately 140 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Emeren Group (SOL) has an Altman Z-Score of -0.29, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Emeren Group (SOL) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Emeren Group (SOL) reported a net loss of $12.5M while operations used $4.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Emeren Group (SOL) reported an operating loss of $504K against $800K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Emeren Group (SOL) scores 64 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top